UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~July~~December 15, 2015



______________________RBC Life Sciences, Inc.______________________ (Exact name of registrant as specified in its charter)
_______NEVADA_______ (State or other jurisdiction of incorporation)	_______000-50417_________ (Commission File Number)	_______91-2015186________ (IRS Employer Identification No.)
2301 CROWN COURT, IRVING, TEXAS (Address of principal executive offices)		____________75038_____________ (Zip Code)
Registrant's telephone number, including area code __________972-893-4000______________
__________________________N/A____________________________ (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):



[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 28.01 ~~Completion~~Other ~~of Acquisition or Disposition of Assets.~~Information

On ~~July~~ December 15, 2015, ~~RBC~~ ~~Life~~the ~~Sciences,~~Board ~~Inc.,~~of ~~formerly~~Directors ~~Royal~~of ~~Bodycare~~RBC Life Sciences, Inc., (the “Company”) ~~completed~~approved ~~the~~a ~~previously~~plan ~~announced~~to ~~sale~~terminate ofand ~~its~~suspend ~~headquarters~~the ~~building~~registration ~~and~~of ~~related~~its ~~parcel~~common ofstock ~~land~~with inthe ~~Irving,~~Securities ~~Texas~~and Exchange Commission (the ~~"Facility"~~“SEC”) ~~for approximately $5~~.18 ~~million.~~In ~~The~~accordance ~~sale~~with ~~was~~this ~~consummated~~plan, ~~under~~on ~~the~~or ~~terms~~about ofJanuary 15, 2016, the ~~Commercial~~Company ~~Contract~~intends ofto ~~Sale~~file ~~entered~~Form ~~into~~15 bywith the ~~Company~~SEC onto ~~April~~voluntarily 9,deregister ~~2015,~~its ascommon ~~subsequently~~stock ~~modified~~and onsuspend ~~April~~its ~~29,~~reporting ~~2015~~obligations ~~and~~under ~~May 26, 2015 (~~the ~~"Sale~~Securities ~~Agreement").~~Exchange ~~After~~Act ~~repayment~~ of ~~outstanding~~1934, ~~mortgage~~as ~~debt secured by the Facility of approximately $1~~amended.13 ~~million~~The ~~and~~Company ~~payment~~is ofeligible ~~other~~to ~~closing~~file ~~costs~~Form ~~and~~15 ~~adjustments,~~because ~~the~~there ~~Company~~are ~~received~~fewer ~~net~~than ~~cash~~300 ~~proceeds~~holders of ~~approximately~~record ~~$3.75~~of ~~million~~its ~~pursuant~~common ~~to the Sale Agreement~~stock. ~~The~~As ~~foregoing~~a ~~summary~~result ~~description~~ of the ~~Sale~~filing ~~Agreement~~of ~~does~~Form ~~not purport~~15, tothe beCompany’s ~~complete~~obligation ~~and~~to isfile ~~qualified~~certain inreports ~~its~~and ~~entirety~~forms bywith ~~reference to~~ the ~~terms~~SEC, ofincluding ~~the~~Forms ~~Sale~~10-K, ~~Agreement~~10-Q, aand ~~copy~~8-K, ofwill ~~which~~cease. ~~was~~Other ~~filed~~filing asrequirements ~~Exhibit~~will ~~10.1~~terminate toupon the ~~Company's~~effectiveness ~~Current~~of ~~Report~~the onderegistration, ~~Form~~which ~~8-K~~is ~~dated~~expected ~~June~~to 3,occur ~~2015~~90 ~~and~~days isafter ~~incorporated~~the ~~herein~~filing byof ~~reference.~~the Form 15.

Effective upon closing of the sale of the Facility, the purchaser, BCKK Investment Group, Inc. (the "Purchaser"), leased the Facility to American Christmas Light & Supply, Inc. (the "Lessee"), which in turn subleased the Facility to the Company. The Commercial Lease Agreement between the Purchaser and Lessee and the Commercial Sublease Agreement between the Lessee and the Company are included as Exhibits 10.1 and 10.2, respectively, to this Form 8-K. Among other provisions, the Commercial Sublease Agreement provides a lease term ending April 30, 2016 and rent of approximately $35,000 per month. The foregoing summary descriptions of the Commercial Lease Agreement and the Commercial Sublease Agreement do not purport to be complete and are each qualified in their entirety by reference to the terms of the Commercial Lease Agreement and the Commercial Sublease Agreement, respectively.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No. Description

10.1 Commercial Lease Agreement dated July 15, 2015 between BCKK Investment Group, Inc. and American Christmas Light & Supply, Inc.

10.2 Commercial Sublease Agreement dated July 15, 2015 between American Christmas Lights & Supply, Inc., and the Company.

10.3 Commercial Contract of Sale between the Company and Decor Pro LLC, as modified, dated April 9, 2015 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the Company with the SEC on June 3, 2015).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: ~~July~~December 21, 2015

RBC Life Sciences, Inc.

By: /s/ Daley L. Seeker

Name: Daley L. Seeker

Title: Vice President-Finance and Chief Financial Officer

Exhibit Index

Exhibit Number	Description
10.1	Commercial Lease Agreement dated July 15, 2015 between BCKK Investment Group, Inc. and American Christmas Light & Supply, Inc.
10.2	Commercial Sublease Agreement dated July 15, 2015 between American Christmas Lights & Supply, Inc., and the Company.
10.3	Commercial Contract of Sale between the Company and Decor Pro LLC, as modified, dated April 9, 2015 (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the Company with the SEC on June 3, 2015).

Filing Compare · RBC LIFE SCIENCES, INC.